Quidel, a provider of rapid diagnostic testing solutions and cell-based virology assays, has received the CE mark for its Quidel molecular RT-PCR assay for human metapneumovirus.

The RT-PCR tests will provide enhanced ease of use, reduced processing time and ready-to-use reagent configurations.

The announcement follows the notice of the European launch of Quidel’s first molecular diagnostic test, a RT-PCR test for Influenza A+B.

The human metapneumovirus assay is not available in the US.